FDA Lays Out Proposed Ground Rules for Natural History Studies

Drug Industry Daily
A A
Drug sponsors who want to use natural histories to help develop treatments for rare diseases should draw up well-defined statistical analysis plans and probably even hire statisticians to help develop the histories, the FDA said in new draft guidance issued Friday.

To View This Article:

Login

Subscribe To Drug Industry Daily